LRA Applauds GSK on Positive Phase 3 Study of Benlysta® for Lupus Nephritis

NEW YORK, Sept. 16, 2020 /PRNewswire/ -- The Lupus Research Alliance welcomes positive BLISS-LN Phase 3 data published in this week's New England Journal of Medicine, demonstrating that GSK's drug BenlystaR (belimumab) significantly improved kidney function in adults with lupus nephritis,...